[Federal Register Volume 68, Number 189 (Tuesday, September 30, 2003)]
[Notices]
[Pages 56294-56295]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-24797]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Vaccine Advisory Committee

AGENCY: Office of the Secretary, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (DHHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold a 
meeting. The meeting is open to the public.

DATES: The meeting will be held on October 7, 2003, from 9 a.m. to 5 
p.m., and on October 8, 2003, from 8:30 a.m. to 3:15 p.m.

ADDRESSES: Department of Health and Human Services; Room 705A Humphrey 
Building; 200 Independence Avenue, SW., Washington, DC 20201.

FOR FURTHER INFORMATION CONTACT: Ms. Carolin Commodore, Staff 
Assistant, National Vaccine Program Office and Executive Secretary, 
National Vaccine Advisory Committee; U.S. Department of Health and 
Human Services, Room 725H Hubert H. Humphrey Building, 200 Independence 
Avenue, SW., Washington, DC 20201; (202) 260-1253.

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Service Act (42 U.S.C. 300aa-1), the Secretary of Health and Human 
Services was mandated to establish the National Vaccine Program (NVP) 
to achieve optimal prevention of human infectious diseases through 
immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The Secretary designated the Assistant Secretary 
for Health to serve as the Director, NVP. The National Vaccine Advisory 
Committee (NVAC) was established to provide advice and make 
recommendations to the Director, NVP, on matters related to the 
program's responsibilities. Topics to be discussed at the meeting 
include: The Institute of Medicine's (IOM) vaccine safety reviews and 
the recent IOM report on vaccine financing; a status report on the 
nation's smallpox vaccine program, and an overview of the SARS vaccine 
research and development at the National Institutes of Health (NIH). 
Updates will be given on activities at the NIH's Vaccine Research 
Center, pandemic influenza preparedness planning, and a status report 
on the West Nile virus vaccine. A tentative agenda will be made 
available for review on the NVPO Web site.
    Public attendance at the meeting is limited to space available. 
Individuals must provide a photo ID for entry into the Humphrey 
Building. Individuals who plan to attend and need special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should notify the designated contact person. Members of 
the public will have the opportunity to provide comments at the 
meeting. Public comment will be limited to five minutes per speaker. 
Any members of the public who wish to have printed material distributed 
to NVAC members should submit materials to the Executive Secretary, 
NVAC, whose contact information is listed above prior to close of 
business October 3, 2003. Preregistration is required for both public 
attendance and comment. Any individual who wishes to attend the meeting 
and/or participate in the public comment session should call the 
telephone number listed in the contact information to register.
    The National Vaccine Program Office will be organizationally 
relocated to the Office of Public Health and Science on October 1. Due 
to administrative matters impacting this organizational relocation, 
this notice is being published less than 15 days in advance of the 
meeting.


[[Page 56295]]


    Dated: September 24, 2003.
Bruce G. Gellin,
Director, National Vaccine Program Office and Executive Secretary, 
National Vaccine Advisory Committee.
[FR Doc. 03-24797 Filed 9-29-03; 8:45 am]
BILLING CODE 4150-28-P